StockWatch
·

AHLUWALIA CONTRACTS (INDIA) LTD. Q2 FY27 Results

AHLUCONTQ2 FY27 Results
Filing
Result:Weak· Market: Surged#Margin squeeze#Cost led
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.5K30.0%32.9%
Total Income1.5K29.5%33.2%
Expenditure1.4K24.5%31.2%
PBT75.56390.6%57.1%
Net Profit56.09439.9%56.8%
OPM7.58%3.29pp2.27pp
NPM3.80%2.89pp2.06pp
EPS0.00100.0%100.0%
View full financials

Infra core metric (adjusted PAT/margin trend) deteriorated sharply — PAT -28.6% YoY on OPM compression to 7.58% from ~9.9-10.9%, driven by rising material costs, despite healthy 24.3% revenue growth.

Q2 FY-2027 RESULTS · AHLUCONT

Ahluwalia Q2 FY27: PAT Falls 29% YoY to ₹56 Cr as Margins Compress, Revenue Up 24%

PAT -28.6% YoY · revenue +24.3% · margins compressing

14 Nov 2026 · 3 min read
Revenue

₹1,463.66 Cr

+24.3% YoY

PAT (consolidated)

₹56.09 Cr

-28.6% YoY

Net margin

3.8%

-2.1pp YoY

EPS

₹8.37

Ahluwalia Contracts' consolidated PAT fell 28.6% year-on-year to ₹56.09 Cr for Q2 FY27 (from ₹78.57 Cr in Q2 FY26), even as revenue from operations grew 24.3% YoY to ₹1,463.66 Cr (₹1,177.30 Cr a year ago). The quarter continues the margin story that has dominated the last two prints: topline is growing in line with, or ahead of, management's stated FY27 target, but profitability hasn't kept pace, with net margin compressing to 3.8% from 6.7% in Q2 FY26 (consolidated). Standalone tracked within 0.4% of consolidated (PAT ₹55.86 Cr), confirming the parent drives the group result; no exceptional items appear in either the current or comparative periods, so the YoY decline is operating, not one-off.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹1,463.66 Cr+30%-32.9%
Expenses₹1,402.27 Cr+24.5%-31.2%
PAT₹56.09 Cr+440%-28.6%
Net margin3.8%+2.9pp-2.1pp
EPS₹8.37+440%-56.8%

The squeeze sits on the operating line: our back-calculated EBITDA margin (OPM) was 7.58% this quarter, down roughly 335 bps from ~10.9% in Q2 FY26, driven by cost of materials consumed rising to 47.0% of revenue (from 40.4% a year ago), with sub-contract work holding near 29-30% of revenue in both periods. The relief, though, is sequential: OPM recovered to 7.58% from Q1 FY27's reported 4.3% — the multi-year low our pre-result preview flagged as 'the litmus test' for this quarter. On that basis the print delivers: PAT of ₹56.09 Cr beat the ₹40-50 Cr we'd estimated, revenue of ₹1,463.66 Cr cleared the ₹1,120-1,150 Cr range expected, and 7.58% OPM beat the 5-6% bar we'd set for 'relief.'

₹
460.64564.91669.18773.44877.7152808-1109-0209-2510-2111-1211-13
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹528, down 8.9% over the past month of trading.

₹ Cr
048.4596.9145.3551.21Q1 FY26rev ₹1,005 Cr129.78Q2 FY26rev ₹2,182 Cr54.06Q3 FY26rev ₹1,061 Cr82.02Q4 FY26rev ₹1,322 Cr10.39Q1 FY27rev ₹1,126 Cr56.09Q2 FY27rev ₹1,464 Cr
Quarterly consolidated PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

EPS (basic, consolidated) ₹8.37 for the quarter vs ₹11.73 in Q2 FY26 and ₹1.55 in Q1 FY27.

What management guided (1 FY-2027 call)
FY27 revenue growth 12–15% (maintained 15%, NGT downside 12%). EBITDA margins ruled out for FY27; aspire for double-digit in FY28. Order inflow revised down to ₹4,000–5,000 Cr from ₹8,000 Cr.

— This quarter: beat

Management's prior guidance (Q1 FY27 concall, defensive tone) maintained FY27 revenue growth at 12-15%, explicitly ruled out double-digit EBITDA margins for FY27 (deferring that to FY28), and cut order-inflow guidance to ₹4,000-5,000 Cr from ₹8,000 Cr. H1 FY27 revenue of ₹2,589.48 Cr is up 18.7% YoY — running at the top of, or ahead of, that growth band — while this quarter's single-digit OPM is consistent with, not a miss against, the company's own margin caution. We found no Q2-specific analyst PAT consensus in public previews; the only quantified benchmark on record is our own pre-result estimate, against which this is a clear beat. Sell-side sentiment (10 of 11 analysts rated the stock BUY per our preview, median target ₹929) framed the margin pain as cyclical, with labour-cost normalisation expected in H2 — this quarter's sequential OPM recovery is an early, partial data point in that direction, not confirmation. Corporate activity this quarter — the ₹310 Cr Bennett University win (Oct 14) and the FY26 dividend payout (Oct 17) — is routine and doesn't materially move this print; the pending NCLT/NCLAT amalgamation appeal involving five subsidiaries remains unresolved before the Supreme Court, per the filing's notes.

  • W1

    Whether OPM keeps climbing toward management's 'double-digit by FY28' aspiration — 7.6% this quarter is the new checkpoint.

  • W2

    Order inflow against the revised ₹4,000-5,000 Cr FY27 guidance (cut from ₹8,000 Cr), tracked after the ₹310 Cr Bennett University win (Oct 14, 2026).

  • W3

    Whether H2 FY27 revenue growth moderates toward the guided 12-15% band after H1's 18.7% YoY pace, or sustains the beat.

Informational and educational content only. Not investment advice.